🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Alain Mina

National Institutes of Health

ORCID: 0000-0002-4388-4825

Also affiliated with National Cancer Institute, Center for Cancer Research

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 7%percentile

0.104Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

A phase 2 study of single agent ibrutinib for first‐line treatment of chronic graft‐versus‐host disease: A new paradigm and lessons learned

British Journal of Haematology(2025)10.1111/bjh.20069

Top 78%

0.104DataRank

Top 78%1 citations

Noa G. Holtzman, Rania Hishmeh, Alain Mina, Eduard Schulz, Anita Stokes +9 more

Papers

Driven by 16 papers — median percentile 22. Top paper: “Metabolic syndrome prevalence and impact on outcomes in patients with chronic graft-versus-host disease”.

Metabolic syndrome prevalence and impact on outcomes in patients with chronic graft-versus-host disease

Bone Marrow Transplantation(2023)10.1038/s41409-023-02097-y

N/A

0.333DataRank · unranked

7 citations

Filip Pirsl, Seth M. Steinberg, Noa G. Holtzman, Eduard Schulz, Alain Mina +7 more

A phase 2 study of single agent ibrutinib for first‐line treatment of chronic graft‐versus‐host disease: A new paradigm and lessons learned

British Journal of Haematology(2025)10.1111/bjh.20069

Top 78%

0.104DataRank

Top 78%1 citations

Noa G. Holtzman, Rania Hishmeh, Alain Mina, Eduard Schulz, Anita Stokes +9 more

CAR19 monitoring by peripheral blood immunophenotyping reveals histology-specific expansion and toxicity

Blood Advances(2024)10.1182/bloodadvances.2024012637

N/A

0DataRank · unranked

24 citations

Erin Craig, Cesar Gentille Sanchez, Alain Mina, John Tamaresis, Nadia Kirmani +27 more

Advancing drug development in myelodysplastic syndromes

Blood Advances(2024)10.1182/bloodadvances.2024014865

N/A

0DataRank · unranked

12 citations

Kathy L. McGraw, Lea Cunningham, Nina Kim, Emily Y. Jen, Katherine R. Calvo +17 more

The evolution of preclinical models for myelodysplastic neoplasms

Leukemia(2024)10.1038/s41375-024-02181-2

N/A

0DataRank · unranked

11 citations

Steven Z. Pavletic, Peter D. Aplan, Alain Mina

Infections and antimicrobial prophylaxis in patients with myelodysplastic syndromes

Seminars in Hematology(2024)10.1053/j.seminhematol.2024.07.004

N/A

0DataRank · unranked

5 citations

Eduard Schulz, Alain Mina, Juan Gea‐Banacloche, Mary M. Czech

Breaking Boundaries: Immunotherapy for Myeloid Malignancies

Cancers(2024)10.3390/cancers16162780

N/A

0DataRank · unranked

3 citations

Eduard Schulz, Alain Mina, T. N. Gavrilova

Allogeneic hematopoietic cell transplantation in elderly patients with myelodysplastic syndromes: Considerations and challenges

Seminars in Hematology(2024)10.1053/j.seminhematol.2024.10.004

N/A

0DataRank · unranked

3 citations

Steven Z. Pavletic, Alain Mina, Eduard Schulz

Navigating the dynamic landscape of lower-risk MDS: Advances and emerging insights

Blood Reviews(2025)10.1016/j.blre.2025.101301

N/A

0DataRank · unranked

2 citations

Yazan F. Madanat, Yasmin Abaza, Amer M. Zeidan, Alain Mina

Iron chelation therapy in myelodysplastic syndromes and allogeneic hematopoietic cell transplantation, a delicate balance

Blood Reviews(2025)10.1016/j.blre.2025.101319

N/A

0DataRank · unranked

2 citations

Eduard Schulz, Steven Z. Pavletic, Alain Mina, Fieke W. Hoff

Luspatercept for patients with lower-risk myelodysplastic syndromes/neoplasms: a systematic review and meta-analysis

Blood Advances(2025)10.1182/bloodadvances.2025017611

N/A

0DataRank · unranked

2 citations

Naira Link Woite, Benjamin Rolles, Jessica M. Stempel, Alain Mina, Lourdes Mendez +7 more

Diagnostic approaches for haematopoietic cell transplantation‐associated membranous nephropathy: Novel underutilized tools

British Journal of Haematology(2025)10.1111/bjh.20232

N/A

0DataRank · unranked

0 citations

Meryl Waldman, Eduard Schulz, Alain Mina, Grace Li, Ashley Carpenter +6 more

Development of a SIN1 Targeting Inhibitor as a Novel Therapeutic Approach for the Treatment of Malignancies

Molecular Cancer Therapeutics(2025)10.1158/1535-7163.mct-25-0298

N/A

0DataRank · unranked

0 citations

Atul Jain, Matt Clutter, Dominik A. Nahotko, Emely Lopez Fajardo, Purav P. Vagadia +20 more

Inhibitory effects of Tomivosertib in acute myeloid leukemia

Oncotarget(2021)10.18632/oncotarget.27952

N/A

0DataRank · unranked

10 citations

Gavin T. Blyth, Alain Mina, Ewa M. Kościuczuk, Blazej Dolniak, Shira Dinner +6 more

Acute myeloid leukemia after myeloproliferative neoplasms: Real‐world outcomes in the new treatment era in the United States

Cancer(2026)10.1002/cncr.70415

N/A

0DataRank · unranked

0 citations

Rong Wang, Lourdes Mendez, Alain Mina, Luis E. Aguirre, Maximilian Stahl +4 more

Collection of peripheral blood mononucleated cells for chronic graft-versus-host disease immunology research: safety and effectiveness of leukapheresis in 132 patients

Journal of Translational Medicine(2022)10.1186/s12967-022-03708-w

N/A

0DataRank · unranked

0 citations

Lauren M. Curtis, Kamille A. West, Yu Ying Yau, Edward W. Cowen, Frances T. Hakim +2 more